Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019031963) HUMAN MILK OLIGOSACCHARIDE FOR IMPROVING IMMUNE FITNESS
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/031963 International Application No.: PCT/NL2018/050481
Publication Date: 14.02.2019 International Filing Date: 12.07.2018
IPC:
A61P 37/00 (2006.01) ,A23L 33/125 (2016.01) ,A61K 31/702 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
[IPC code unknown for A23L 33/125]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
702
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Applicants:
N.V. NUTRICIA [NL/NL]; Eerste Stationsstraat 186 2712 HM Zoetermeer, NL
Inventors:
POTAPPEL-VAN 'T LAND, Belinda; NL
VAN DEN ELSEN, Lieke Wilhelmina Johanna; NL
STAHL, Bernd; NL
Agent:
NEDERLANDSCH OCTROOIBUREAU; P.O.Box 29720 2502 LS The Hague, NL
Priority Data:
PCT/NL2017/05053211.08.2017NL
Title (EN) HUMAN MILK OLIGOSACCHARIDE FOR IMPROVING IMMUNE FITNESS
(FR) OLIGOSACCHARIDE DE LAIT HUMAIN PERMETTANT D'AMÉLIORER LA CONDITION PHYSIQUE IMMUNITAIRE
Abstract:
(EN) The invention concerns the use of fucosylated non-digestible human milk oligosaccharide, or composition comprising a fucosylated non-digestible human milk oligosaccharide, for use in improving immune fitness in a human subject, wherein the human subject is male.
(FR) L'invention concerne l'utilisation d'un oligosaccharide de lait humain non digestible fucosylé, ou une composition comprenant un oligosaccharide de lait humain non digestible fucosylé destinée à être utilisée pour améliorer la condition physique immunitaire chez un sujet humain, le sujet humain étant de sexe masculin.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)